Print
Email
Print Edition Stories
MHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges
Funding drugs for rare diseases
MHT's Julie Donnelly: Life science startups finding investments
A Northeastern University researcher has won a $1.4 million grant from the National Institutes of Health to develop nanocarrier drug delivery technology.
Vladimir Torchilin, a professor pharmaceutical sciences and the director of Northeastern’s Center for Pharmaceutical Biotechnology and Biomedicine, will use the funding to combine pharmaceutical nanotechnology with a new drug coating process. The combination of techniques is intended to carry insoluble drugs to their targets inside the body. The technique could make drugs passed over for their insolubility viable drug candidates again.
Torchilin will collaborate with researchers from Louisiana Tech University on the four-year grant.
In 2008, Torchilin won $1.5 million from the NIH for research on nanoscale pharmaceuticals.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
